CTRP1 Antibodies

Santa Cruz Biotechnology delivers a wide array of CTRP1 monoclonal antibodies for research focused on understanding CTRP1 protein functions. Multiple detection methods are supported, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CTRP1, or C1q/TNF-related protein 1, belongs to the CTRP family and plays a significant role in metabolic regulation, particularly in glucose and lipid metabolism. Research has shown CTRP1's involvement in inflammation and insulin sensitivity pathways. Scientists studying metabolic disorders and obesity frequently investigate CTRP1 to develop new therapeutic approaches. Understanding CTRP1's molecular mechanisms can reveal potential treatment strategies for metabolic conditions. Recent studies have highlighted CTRP1's importance in maintaining metabolic homeostasis. Ongoing research continues to uncover new functions and regulatory pathways associated with CTRP1. Santa Cruz Biotechnology monoclonal antibodies enable researchers worldwide to advance scientific understanding of CTRP1's role in human health and disease.